Latest International Markets News

Zeotech Limited has signed a non-binding Letter of Intent with Bisley & Company to explore marketing and distribution of its high-reactivity metakaolin product, AusPozz™, across Australia and key international markets.

Paradigm Biopharmaceuticals has drawn down US$5 million under its convertible note facility to fund the accelerated expansion of its global Phase 3 trial for knee osteoarthritis treatment.

Airtasker Limited has announced a $10 million equity capital raise to accelerate marketing efforts in the UK and US, following a strong first quarter with group revenue up 20.5% year-on-year. Strategic partnerships, including a cornerstone investment from iHeartMedia, underpin its international growth ambitions.

Airtasker has raised $10 million in a strategic equity placement led by iHeartMedia, aiming to accelerate its growth in the US and UK markets through targeted marketing and expanded media partnerships.

Bioxyne Limited is expanding its footprint with a new UK GMP-certified medicinal cannabis manufacturing site, backed by £850,000 in funding from South of Scotland Enterprise. This move positions the company to tap into the UK’s growing medicinal cannabis market, the second largest in Europe.

Bio-Gene Technology’s natural insecticide Qcide® has earned organic listing status from the US Organic Materials Review Institute, marking a pivotal step for its entry into the organic pest control market.

Antilles Gold has launched a substantial infill drilling program at its La Demajagua mine in Cuba, setting the stage for a Definitive Feasibility Study that could unlock enhanced resource value amid soaring gold, silver, and antimony prices.

Lycopodium Limited projects steady growth for FY26 with revenue guidance of $390-$410 million, underpinned by strong project momentum and the strategic SAXUM acquisition expanding its footprint in the Americas.

GrainCorp reported a resilient FY25 with underlying EBITDA rising to $308 million, supported by record grain handling and oilseed crush volumes despite a challenging global margin environment. The company maintained a strong balance sheet and returned solid dividends while advancing strategic growth and sustainability initiatives.

MyEco Group reveals a strategic pivot towards expanding its MyEco branded products, achieving a 9% sales increase in FY25, and implementing a $2.5 million cost-saving operational restructure aimed at EBITDA breakeven in FY26.

Xero Limited reported a robust first half of FY26 with 20% revenue growth and strong cash generation, driven by sustained momentum across its core markets and the strategic Melio acquisition expanding its US footprint.

AUB Group delivered a robust FY25 with a 17.1% rise in underlying net profit and a 15% dividend increase, while navigating a $45 per share acquisition proposal from an EQT-CVC consortium.